Open-Label Single-Arm Phase 2 Study of Alimta [Pemetrexed] in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Who Have Had Prior Platinum Based Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 01 Oct 2012
At a glance
- Drugs Pemetrexed (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 15 Feb 2012 Actual patient number (35) added as reported by ClinicalTrials.gov.
- 15 Feb 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 15 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History